Cargando…
CCL21 Cancer Immunotherapy
Cancer, a major health problem, affects 12 million people worldwide every year. With surgery and chemo-radiation the long term survival rate for the majority of cancer patients is dismal. Thus novel treatments are urgently needed. Immunotherapy, the harnessing of the immune system to destroy cancer...
Autores principales: | Lin, Yuan, Sharma, Sherven, John, Maie St. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074818/ https://www.ncbi.nlm.nih.gov/pubmed/24810425 http://dx.doi.org/10.3390/cancers6021098 |
Ejemplares similares
-
Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth
por: Kar, Upendra K., et al.
Publicado: (2011) -
Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine
por: Kadam, Pournima, et al.
Publicado: (2020) -
The promise of immunotherapy in the treatment of young adults with oral tongue cancer
por: Nasser, Hassan, et al.
Publicado: (2020) -
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
por: Srivastava, Minu K, et al.
Publicado: (2012) -
Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
por: Riedl, Karen, et al.
Publicado: (2003)